Muslims have least sex outside marriage: Study

[email protected] (Livescience)
December 31, 2012

Of all the world's major religious groups, Muslims are the least likely to have sex outside of marriage, new research found. And as a country's Muslim population grows, the rate of premarital sex declines for all residents, even non-Muslims, according to the study.

Researchers analyzed the responses of over 620,000 people (ages 15-59) who were interviewed as part of the Demographic and Health Surveys in 31 mostly developing nations from 2000 to 2008. Most countries included in the sample had either a Muslim or Christian majority, except India and Nepal, which have Hindu majorities, and Cambodia which has a Buddhist majority. (The United States was not included in the study.)

They found that, overall, the odds of married Muslims reporting premarital sex are 53 percent lower than for Christians. Hindus are 40 percent less likely to report premarital sex, compared with Christians. Meanwhile, Jews and Buddhists have greater chances of having sex before getting hitched than Christians do, according to the study.image

The researchers believe these results could be linked to Muslims' greater adherence to strict religious tenets that only allow sex within marriage. As many Muslim leaders place heavy importance on fidelity in marriage, it might be no surprise that Muslims also are less likely than Hindus, Christians and Jews to report extramarital sex, as the study found.

What's more, the religious values of a Muslim majority in a country seem to exert a big influence on the wider population's sexual norms. A 1 percent increase in the percentage of Muslims in a nation caused a 2 percent decrease in the likelihood of premarital sex for all citizens, regardless of their religious identity, the study found. (The researchers note that an increase in the Muslim population in a country did not further reduce the odds of premarital sex among just Muslims.)

"All major world religions discourage sex outside of marriage, but they are not all equally effective in shaping behavior," wrote the researchers, led by Amy Adamczyk, an associate professor of sociology at John Jay College of Criminal Justice in New York. Their study was published in the October issue of the American Sociological Review.

The team speculated that in Muslim-majority countries, strict laws on women's mobility and interaction between the sexes might cut down the opportunities for sex outside marriage. But the researchers found no significant relationship between a country's restrictions on women and the odds of premarital and extramarital sex, suggesting religion plays a greater role than those laws in policing sexual behavior.

The same was true for age. Muslims and Hindus are more likely to have an arranged marriage and to marry younger than Christians and Jews. Though the likelihood of premarital sex increased with age, the study found that age was not a significant factor in driving down rates of premarital sex for these religious groups.

"One of the most surprising findings was that religious affiliations have a real influence on people's sexual behaviors," Adamczyk said in a statement. "While a lot of research attention has been given to understanding differences between the major world religions in adherents' attitudes, much less attention has been given to understanding differences based on behaviors."

The researchers considered that social pressure could have caused some respondents being interviewed in the Demographic and Health Surveys (funded by USAID) to lie. But the survey mandates that interviewers be the same gender as the respondent and try to conduct the questionnaire in private. The latter is not always possible and interviewers are instructed to note the presence of others. They are also told to flag inconsistent responses  (For example, if a respondent says she was a virgin at the time of marriage, but her reported age at first intercourse is younger than her age at marriage, that would get flagged.)

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 2,2020

London, Jul 2: The World Health Organisation says smoking is linked to a higher risk of severe illness and death from the coronavirus in hospitalised patients, although it was unable to specify exactly how much greater those risks might be.

In a scientific brief published this week, the U.N. health agency reviewed 34 published studies on the association between smoking and Covid-19, including the probability of infection, hospitalisation, severity of disease and death.

WHO noted that smokers represent up to 18% of hospitalised coronavirus patients and that there appeared to be a significant link between whether or not patients smoked and the severity of disease they suffered, the type of hospital interventions required and patients' risk of dying.

In April, French researchers released a small study suggesting smokers were at less risk of catching Covid-19 and planned to test nicotine patches on patients and health workers — but their findings were questioned by many scientists at the time who cited the lack of definitive data.

WHO says "the available evidence suggests that smoking is associated with increased severity of disease and death in hospitalized Covid-19 patients. It recommends that smokers quit.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 4,2020

Despite tremendous advances in treatment of congenital heart disease (CHD), a new global study shows that the chances for a child to survive a CHD diagnosis is significantly less in low-income countries.

The research revealed that nearly 12 million people are currently living with CHD globally, 18.7 per cent more than in 1990.

The findings, published in The Lancet, is drawn from the first comprehensive study of congenital heart disease across 195 countries, prepared using data from the Global Burden of Diseases, Injuries and Risk Factors Study 2017 (GBD).

"Previous congenital heart estimates came from few data sources, were geographically narrow and did not evaluate CHD throughout the life course," said the study authors from Children's National Hospital in the US.

This is the first time the GBD study data was used along with all available data sources and previous publications - making it the most comprehensive study on the congenital heart disease burden to date.

The study found a 34.5 per cent decline in deaths from congenital disease between 1990 to 2017. Nearly 70 per cent of deaths caused by CHD in 2017 (180,624) were in infants less than one year old.

Most CHD deaths occurred in countries within the low and low-middle socio-demographic index (SDI) quintiles.

Mortality rates get lower as a country's Socio-demographic Index (SDI) rises, the study said.

According to the researchers, birth prevalence of CHD was not related to a country's socio-demographic status, but overall prevalence was much lower in the poorest countries of the world.

This is because children in these countries do not have access to life saving surgical services, they added.

"In high income countries like the United States, we diagnose some heart conditions prenatally during the 20-week ultrasound," said Gerard Martin from Children's National Hospital who contributed to the study.

"For children born in middle- and low-income countries, these data draw stark attention to what we as cardiologists already knew from our own work in these countries -- the lack of diagnostic and treatment tools leads to lower survival rates for children born with CHD," said researcher Craig Sable.

"The UN has prioritised reduction of premature deaths from heart disease, but to meet the target of 'ending preventable deaths of newborns and children under 5 years of age,' health policy makers will need to develop specific accountability measures that address barriers and improve access to care and treatment," the authors wrote.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 26,2020

Tedros Adhanom Ghebreyesus, the World Health Organisation's (WHO) Director-General, said that a clinical trial of hydroxychloroquine (HCQ) on COVID-19 patients has come to "a temporary pause", while the safety data of the the anti-malaria drug was being reviewed.

According to the WHO chief, The Lancet medical journal on May 22 had published an observational study on HCQ and chloroquine and its effects on COVID-19 patients that have been hospitalized, reports Xinhua news agency.

The authors of the study reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate.

"The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met on Saturday (May 23) and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally," Tedros said in a virtual press conference on Monday.

The review will consider data collected so far in the Solidarity Trial and in particular robust randomized available data, to adequately evaluate the potential benefits and harms from this drug, he said.

"The Executive Group has implemented a temporary pause of the HCQ arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board. The other arms of the trial are continuing," Tedros added.

WHO initiated the Solidarity Trial, a plan to evaluate the safety and efficacy of four drugs and drug combinations against COVID-19 more than two months ago, which include HCQ.

According to the WHO, over 400 hospitals in 35 countries are actively recruiting patients and nearly 3,500 patients have been enrolled from 17 countries under the Solidarity Trial.

Tedros added that the safety concern over the drug related only to the use of HCQ and chloroquine in COVID-19, and "these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria".

"WHO will provide further updates as we know more," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.